Andrew Ambrosy to Aldosterone
This is a "connection" page, showing publications Andrew Ambrosy has written about Aldosterone.
Connection Strength
0.051
-
A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19. Am Heart J. 2022 May; 247:76-89.
Score: 0.051